Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Inflammatory Bowel Diseases

Free Subscription 02.03.2026 2 Aliment Pharmacol Ther 2 Am J Gastroenterol 1 Clin Gastroenterol Hepatol 4 Dig Dis Sci 1 Eur J Gastroenterol Hepatol 3 Gastroenterology 3 Inflamm Bowel Dis 1 J Clin Gastroenterol 1 J Gastroenterol 1 Lancet Gastroenterol Hepatol 1 PLoS One 2 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. AHUJA D, Yeh KH, Patel SB, Park SK, et al
   Research Communication: Risk of Tuberculosis With Advanced Therapies in 20,705 Patients With Inflammatory Bowel Diseases in Low Incidence Regions-A U.S. Claims-Based Study.
   Aliment Pharmacol Ther. 2026;63:885-887.
   PubMed         Abstract available
   
   
2. FAYE AS, Axelrad J, Sun J, Halfvarsson J, et al
   Treatment-Free Outcomes Following Surgery for IBD: A Nationwide Cohort Study.
   Aliment Pharmacol Ther. 2026;63:821-837.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

3. BHAT S, Falaiye T, Moses J, Lukin DJ, et al
   The Costs of Inflammatory Bowel Disease and the Financial Impact of Insurance Delays.
   Am J Gastroenterol. 2026 Feb 27. doi: 10.14309/ajg.0000000000003975.
   PubMed         Abstract available
   
   
4. HARRIS HM, Ghoneim S, Kochar B, Casey K, et al
   Differences in Outcomes following Ileocecal Resection in Older Adults with Crohn's Disease in the Biologic Era.
   Am J Gastroenterol. 2026 Feb 25. doi: 10.14309/ajg.0000000000003978.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

5. AHUJA D, Yeh KH, Patel SB, Lee HH, et al
   Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
   Clin Gastroenterol Hepatol. 2026;24:794-804.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

6. MAHADEVAN U, Sands BE, Ha C, Yimgang D, et al
   Epidemiology and Treatment of Inflammatory Bowel Disease in Pregnancy: Results from a Retrospective, Observational Study.
   Dig Dis Sci. 2026 Feb 25. doi: 10.1007/s10620-026-09725.
   PubMed         Abstract available
   
   
7. BLACHIER F
   Reduced Mitochondrial Oxidative Phosphorylation in Colonic Explants and Ulcerative Colitis: Dangerous Liaisons.
   Dig Dis Sci. 2026 Feb 23. doi: 10.1007/s10620-026-09755.
   PubMed        
   
   
8. DUPENLOUP P, Selnes O, Streett SE, Brandeau ML, et al
   Infliximab Monotherapy Versus Infliximab and Azathioprine Combination Therapy in Patients with Ulcerative Colitis: A Cost-Effectiveness Analysis.
   Dig Dis Sci. 2026 Feb 22. doi: 10.1007/s10620-026-09761.
   PubMed         Abstract available
   
   
9. SONG JH, Seong G, Shin J, Kong SM, et al
   Effect of Concomitant Immunomodulator Use by UST-CDST Classification on Clinical Relapse in Crohn's Disease Patients Treated with Ustekinumab: A Multicenter Study.
   Dig Dis Sci. 2026 Feb 21. doi: 10.1007/s10620-026-09760.
   PubMed         Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

10. FOTEINOGIANNOPOULOU K, Nikolaou P, Orfanoudaki E, Theodoraki E, et al
    The rate and risk factors for malignancy in patients with inflammatory bowel disease in Crete: a case control study.
    Eur J Gastroenterol Hepatol. 2026;38:327-332.
    PubMed         Abstract available
    
    

    
    Gastroenterology

11. BOURGONJE AR, Mian P
    Rethinking Infliximab Dosing in Acute Severe Ulcerative Colitis with Model-Informed Precision Dosing.
    Gastroenterology. 2026 Feb 23:S0016-5085(26)00152.
    PubMed        
    
    
12. BOSSUYT P, Rahier JF, Baert F, Louis E, et al
    The effect of dose-intensification after secondary loss of response to ustekinumab in Crohn's disease: Results of the REScUE study.
    Gastroenterology. 2026 Feb 24:S0016-5085(26)00146.
    PubMed         Abstract available
    
    
13. DUBOIS L, Chaussard A, Seksik P, Nancey S, et al
    Uncovering the dynamics of mucosa-associated microbiota in post-operative recurrence of Crohn's disease.
    Gastroenterology. 2026 Feb 24:S0016-5085(26)00147.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

14. HARPAZ N, Odze RD
    Updated pathologic classification of inflammatory bowel disease-associated colorectal dysplasia: A guide for clinicians.
    Inflamm Bowel Dis. 2026 Feb 27:izag011. doi: 10.1093.
    PubMed         Abstract available
    
    
15. NAPOLITANO D, Bozzetti M, Vanzi V, Lo Cascio A, et al
    Bowel urgency in inflammatory bowel disease: A concept analysis.
    Inflamm Bowel Dis. 2026 Feb 25:izag018. doi: 10.1093.
    PubMed         Abstract available
    
    
16. PAL P, Mateen MA, Sekaran A, Naaz SM, et al
    Comparing diagnostic accuracy of transperineal ultrasound using microconvex probe versus conventional linear probe to predict rectal histoendoscopic activity in ulcerative colitis: a paired prospective, head-to-head comparative study.
    Inflamm Bowel Dis. 2026 Feb 25:izag016. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Clin Gastroenterol

17. FERRANTE M, Christensen B, Bressler B, Brett NR, et al
    Real-World Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naive Patients With Crohn's Disease: Results From the EVOLVE Expansion Chart Review Study.
    J Clin Gastroenterol. 2026 Feb 24. doi: 10.1097/MCG.0000000000002350.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

18. WANG X, Tu Y, Zhang S, Che T, et al
    Severity of surgical histopathological fibrosis predicted postoperative recurrence in Crohn's disease: a multi-center retrospective cohort study.
    J Gastroenterol. 2026 Feb 26. doi: 10.1007/s00535-026-02374.
    PubMed         Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

19. OLDENBURG L, Haanappel AEG, Ali M, Bosman C, et al
    Ileocaecal resection versus infliximab for ileal Crohn's disease: retrospective 10-year follow-up of the LIR!C trial.
    Lancet Gastroenterol Hepatol. 2026 Feb 19:S2468-1253(25)00374.
    PubMed         Abstract available
    
    

    
    PLoS One

20. ABOU RACHED A, Saniour J, Geagea A, Salameh C, et al
    Updated data on the epidemiology of Inflammatory Bowel Disease (IBD) in Lebanon.
    PLoS One. 2026;21:e0340892.
    PubMed         Abstract available
    
    

    
    Scand J Gastroenterol

21. GUNNARSSON J, Mavroudis G, Agren S, Lasson A, et al
    Adalimumab and infliximab are equally efficient in achieving sustained remission in ulcerative colitis but infliximab is superior in severe disease-a retrospective observational study.
    Scand J Gastroenterol. 2026 Feb 22:1-11. doi: 10.1080/00365521.2026.2633732.
    PubMed         Abstract available
    
    
22. BOUWKNEGT DG, Donker HC, van Es B, Dijkstra G, et al
    Liver enzyme alterations during pregnancy in IBD are not attributable to disease activity or medication.
    Scand J Gastroenterol. 2026;61:317-328.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum